Female       Male       30days (x) 60days (y) 120days (z)   30days (x) 60days (y) 120days (z)   GSH Med (Min-Max) Med (Min-Max) Med (Min-Max) p Med (Min-Max) Med (Min-Max) Med (Min-Max) p Control (n=6) e445,5(250,0-570,0)y 189,0(173,0-231,0)x,z 391,0(333,0-417,0)y 0,003* 189,0(179,0-308,0)z 186,0(160,0-212,0)z 391,0(263,0-417,0)x,y 0,004* 1% (n=6) e432,5(288,0-583,0)y 195,5(173,0-327,0)x,z 394,0(333,0-442,0)y 0,003* 214,5(192,0-276,0)z 199,0(173,0-231,0)z 388,0(288,0-436,0)x,y 0,002* 2,5% (n=6) e432,5(231,0-583,0)y 205,0(173,0-224,0)x,z 404,0(353,0-500,0)y 0,003* 272,5(20,0-288,0)y 189,0(160,0-244,0)x,z 269,0(250,0-455,0)y 0,016* 5% (n=6) e455,0(321,0-526,0) 256,5(173,0-641,0) 413,0(308,0-506,0) 0,082 208,5(179,0-231,0)z 237,5(160,0-308,0)z 375,0(282,0-391,0)x,y 0,003* 10% (n=6) a,b,c,d230,5(205,0-263,0)z 240,5(154,0-378,0)z 400,5(365,0-513,0)x,y 0,004* 224,0(212,0-250,0)z 211,5(160,0-391,0)z 375,0(269,0-455,0)x,y 0,008* p 0,014* 0,483 0,760   0,272 0,458 0,330   GSH in female genders of 30th day; %10<control=%1=%2,5=%5. GSH, control group of female genders; 30th day>60th day and 120th day>60th day. GSH in same genders of %1 group;30th day>60th day and 120th day>60th day. GSH in same genders of %2,5 group; 30th day>60th day and 120th day>60th day. And GSH in same genders of %10 group; 30th day<120th day and 60th day<120th day. GSH in male genders of control group; 30th day<120th day and 60th day<120th day. GSH in same genders of %1 group; 30th day<120th day and 60th day<120th day. GSH in same genders of %2,5 group; 30th day>60th day and 120th day>60th day. GSHin same genders of %5 group; 30th day<120th day and 60th day<120th day. And GSHin same genders of %10 group; 30th day<120th day and 60th day<120th day.

Table 4: Effects of three different periods and four different SDOA supplementation rates on large intestine GSH (nmol/g ) levels in rats.